Homocysteine disulfide

Tyrosine Cysteine-homocysteine disulfide 3-Methoxytyrosine Erythromycin glucoheptonate... 

The biochemical phenotype of homocystinuria is characterized by increased plasma concentrations of methionine, free homocysteine and cysteine-homocysteine disulfide, together with low cystine (Figure 55-6, C). Determination of total homocysteine after treatment of the sample with... 

The diagnosis of homocystinuria is based on the recognition of the clinical phenotype in conjunction with the identification of an elevated total plasma homocysteine and elevated plasma methionine concentrations (via quantitative plasma amino acid analysis). Low cystine and low cystathionine are also seen (Box 14.3). In addition, increased urinary excretion of homocysteine as well as cysteine-homocysteine disulfide can be identified on urine amino acid analysis. Confirmation of the diagnosis can be done via enzyme assay, typically performed on cultured skin fibroblasts, lymphocytes, or liver tissue, or via molecular studies. 

Homocysteine is an intermediate sulfur amino acid. Normal fasting homocysteine levels in plasma are between 5 and 15 pmol/1. Hyperhomocysteinemia are considered to be moderate between 16 and 30 pmol/l, intermediate (31 lOOpmol/1) and severe > 100 pmol/1. In plasma, 70-80% of homocysteine is bound to plasma proteins and 20-30% is free homocysteine circulating as homocysteine disulfide (homocystine) or mixed disulfides (cysteine-homocysteine). Folate deficiency leads to the decrease of homocysteine... 

There are numerous abnormalities of cysteine metabolism. Cystine, lysine, arginine, and ornithine are excreted in cystine-lysinuria (cystinuria), a defect in renal reabsorption. Apart from cystine calculi, cystinuria is benign. The mixed disulfide of L-cysteine and L-homocysteine (Figure 30-9) excreted by cystinuric patients is more soluble than cystine and reduces formation of cystine calculi. Several metabolic defects result in vitamin Bg-responsive or -unresponsive ho-mocystinurias. Defective carrier-mediated transport of cystine results in cystinosis (cystine storage disease) with deposition of cystine crystals in tissues and early mortality from acute renal failure. Despite... 

Rabenstein and Yamashita [52] determined penicillamine and its symmetrical and mixed disulfides by HPLC in biological fluids. Plasma and urine were deproteinized with trichloroacetic acid, and HPLC was performed on a column (25 cm x 4.6 mm) or Biophase ODS (5 pm) with a mobile phase comprising 0.1 M phosphate buffer (pH 3) and 0.34 mM Na octylsulfate at 1 mL/min. Detection was with a dual Hg-Au amalgam electrode versus a Ag-AgCl reference electrode. (z>)-penicillamine and homocysteine were determined at the downstream electrode at +0.15 V, and homocystine, penicillamine-homocysteine, and penicillamine disulfides were first reduced... 

Immobilized dihydrolipoamide (thioctic acid) (Gorecki and Patchornick, 1973 Gorecki and Patchornick, 1975) and immobilized N-acetyl-homocysteine thiolactone (Eldjarn and Jellum, 1963 Jellum, 1964) are the two most commonly used immobilized disulfide reductants. In addition, immobilized TCEP provides a reducing matrix that is free of thiols (Thermo Fisher). Such immobilized reductants successfully can be used to reduce many types of biological disulfides, including small molecules like oxidized glutathione and bovine insulin. They... 

DMS is formed during the biodegradation of organic sulfur compounds and by the biological methylation of sulfide and methanethiol. Precursors of DMS are methionine, S-methylmethionine, dimethylsulfoniopropionate (DMSP), dimethylsulfonioacetate (DMSA), dimethyl sulfoxide (DMSO), methionine sulfoxide and sulfone, trimethylsulfonium salts, S-methylcysteine, homocysteine, dimethyl disulfide (DMDS), 2-keto-4-methiolbutyrate, and 2-mercaptoacetate (thioglycollate). 

The fraction of intracellular homocysteine that does not undergo transsulfuration or remethylation is secreted into the extracellular space and ultimately finds its way into the blood. One major source of blood homocysteine is the liver, but some homocysteine is secreted into the blood by endothelial cells, circulating blood cells, and other tissues. Only about 2% of homocysteine in blood remains in its reduced, thiol form. The remainder circulates as a variety of different oxidation adducts, which include the disulfide, homocystine, as well as homocysteine-cysteine mixed disulfide and several protein-bound disulfides.About 70% of total homocysteine in blood is bound to the protein albumin through a disulfide linkage.When blood homocysteine is measured in the clinical laboratory, a reducing agent is added to the sample... 

An example of the use of a symmetrical disulfide as a protecting group can be seen in a synthesis of compound 30.4 [Scheme 5.30], a key intermediate in Bristol-Myers Squibb s Omapatrilat.60 The tethered dipeptide derivative 30.2 of homocysteine was cleaved with dithiothreitol and the thiol intermediate treated with methanesulfonic acid to cause a double cyclisation reaction. 

A. Jacobi, D. Seebach, How to Stabilize or Break P-Peptidic Helices by Disulfide Bridges Synthesis and CD Investigation of P-Peptides with Cysteine and Homocysteine Side Chains Helv. Chim. Acta 1999, 82, 1150- 1172. 

Homocystinuria is a genetic disease lhal usually results from defects In the gene coding for cystathionine 3-synthase, and the consequent lack of activity of this enzyme. Typically, the resulting levels of enzyme activity are from 0 to 5 K> the normal value. The disease w as named because of the increased levels of homocysteine in the urine that arise because the plasma levels of this amino acid increase to over 100 jjlM. Actually, urinary homocysteine occurs as the disulfide-linked... 

B. Homocystine is produced when two homocysteine molecules form a disulfide bond. Homocysteine is produced when S -adenosylhomocysteine (SAH) releases adenosine. It is used in the synthesis of cystathionine. Homocysteine accepts a methyl group (from FH4 via vitamin B12) to form methionine. If the enzyme that cleaves adenosine from SAH is deficient, homocysteine levels will decrease. The other deficiencies would lead to increased levels of homocysteine. 

Elevated concentrations of plasma homocysteine (HCY) are related to an increased risk of cardiovascular disease, which exists in numerous forms in plasma, with the main form existing as a disulfide with itself, cysteine, or albumin. Therefore, the first step in the measurement involves treatment with a reducing agent, in this case dithiothreitol (DTT), to obtain HCY in its free form (Eq. 16.34). Some amino acids (e.g., L-cysteine and L-methionine) are present in human plasma at higher molar concentrations than HCY and may interfere with this assay. To avoid this possible interference, the highly selective enzymatic conversion of HCY to S-adenosyl-L-homocysteine (SAH), as shown in Eq. 16.34, is used. Both reactions (reduction and conjugation) are accomplished in 30 min at 34 °C. 

Rubenstein D, Yahashita GT. Determination of homocysteine, penicillamine and their symmetrical and mix disulfides by liquid chromatography with electrochemical detection. Anal Biochem 1989 180 259-63. 

Sulfhydryl group functional in the activity of many enzymes is — responsible for disulfide bridges in peptides and proteins cystine is dicysteine, Gys-S-S Cys homocysteine... 

In plasma, homocysteine is present as both free (< 1 %) and oxidized forms (>99%). The oxidized forms include protein (primarily albumin)-bound homocysteine mixed disulfide (80-90%), homocysteine-cysteine mixed disulfide (5-10%), and homocystine (5-10%). Several studies have shown the relationship between homocysteine and altered endothelial cell function leading to thrombosis. Thus, hyperhomocysteinemia appears to be an independent risk factor for occlusive vascular disease. Five to ten percent of the general population have mild hyperhomocysteinemia. 

Regulation of liver D-fructose 1,6-diphosphatase could involve modification of the sulfhydryl group of the enzyme.397 Cystamine (2,2 -dithiobisethylamine) or homocysteine undergoes a disulfide exchange-reaction with two reactive cysteine residues. This exchange leads to a four-fold increase in catalytic activity.405 Other sulfhydryl reagents, such as l-fluoro-2,4-dinitrobenzene (FDNB), p-mercuri-benzoate (PMB), and 2-iodoacetamide, also activate liver D-fructose... 

Homocysteine is oxidized to a disulfide, homocystine. To indicate that both forms are being considered, the term homocyst(e)ine is used. 

---